Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
00:00
Innovations in CAR T-Cell Therapies for Myeloma
This chapter explores the intricacies of CAR T-cell therapies, specifically Idacel and Siltacel, in treating multiple myeloma. It highlights key differences in efficacy, binding mechanisms, and response rates based on trial data, while addressing ongoing research and the risks of toxicity. Additionally, the chapter emphasizes the importance of therapy sequencing and its impact on patient outcomes, using real case studies to illustrate these complexities.
Transcript
Play full episode
